HIGHLIGHTS
- who: u00c5slaug Helland from the Institute for Cancer Research/Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway have published the article: Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway, in the Journal: (JOURNAL)
- what: The authors will evaluate clinical benefit of approved drugs outside current indication based on extended molecular testing of cancers available through the public health care system in Norway.
- how: The trial applies a new public infrastructure for molecular cancer diagnostics (InPreD) which includes a national molecular tumour board that serve IMPRESS . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.